Caisse Des Depots ET Consignations Invests $50,000 in Everus (NYSE:ECG)

Caisse Des Depots ET Consignations purchased a new stake in shares of Everus (NYSE:ECGFree Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 761 shares of the company’s stock, valued at approximately $50,000.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in ECG. SRS Capital Advisors Inc. bought a new stake in shares of Everus during the 4th quarter worth $26,000. Principal Securities Inc. purchased a new stake in Everus during the fourth quarter worth about $27,000. HighMark Wealth Management LLC bought a new stake in Everus in the fourth quarter worth about $28,000. Crews Bank & Trust purchased a new position in Everus in the fourth quarter valued at about $29,000. Finally, Mendota Financial Group LLC bought a new position in shares of Everus during the 4th quarter valued at approximately $36,000.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. Oppenheimer upped their price objective on Everus from $70.00 to $80.00 and gave the company an “outperform” rating in a research note on Tuesday, January 7th. Stifel Nicolaus dropped their price target on Everus from $85.00 to $67.00 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Finally, Wolfe Research assumed coverage on Everus in a research note on Tuesday, December 3rd. They set a “peer perform” rating for the company.

Read Our Latest Stock Report on ECG

Insider Buying and Selling at Everus

In other news, Director Edward A. Ryan purchased 1,400 shares of the business’s stock in a transaction on Tuesday, February 25th. The stock was purchased at an average cost of $38.02 per share, with a total value of $53,228.00. Following the acquisition, the director now directly owns 14,928 shares in the company, valued at approximately $567,562.56. This trade represents a 10.35 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Rocca Michael Della purchased 1,050 shares of Everus stock in a transaction dated Tuesday, February 18th. The shares were purchased at an average price of $47.56 per share, with a total value of $49,938.00. Following the completion of the transaction, the director now directly owns 2,027 shares in the company, valued at approximately $96,404.12. This represents a 107.47 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 3,750 shares of company stock valued at $153,853 in the last quarter.

Everus Stock Up 3.3 %

ECG opened at $36.11 on Friday. Everus has a 12 month low of $33.90 and a 12 month high of $77.93. The company has a quick ratio of 1.50, a current ratio of 1.58 and a debt-to-equity ratio of 0.47. The business has a 50 day simple moving average of $51.30.

Everus (NYSE:ECGGet Free Report) last posted its earnings results on Tuesday, February 11th. The company reported $0.67 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.73 by ($0.06). As a group, equities analysts forecast that Everus will post 2.49 earnings per share for the current fiscal year.

Everus Profile

(Free Report)

Everus Construction Group is providing a full spectrum of construction services through its electrical and mechanical and transmission and distribution specialty contracting services principally in United States. Its specialty contracting services are provided to utility, transportation, commercial, industrial, institutional, renewable and other customers.

Read More

Want to see what other hedge funds are holding ECG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Everus (NYSE:ECGFree Report).

Institutional Ownership by Quarter for Everus (NYSE:ECG)

Receive News & Ratings for Everus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Everus and related companies with MarketBeat.com's FREE daily email newsletter.